Fear of Cancer Recurrence and Coping Attitudes of Breast Cancer Survivors
Overview
Authors
Affiliations
Objective: This study aimed to determine the fear of cancer recurrence levels and coping orientation of breast cancer survivors.
Methods: This descriptive exploratory study was conducted using a web-based online survey. This article is written using the STROBE checklist. The study was completed with 204 women participants. Data were collected using the 'Demographic and Clinical Information Form', 'Fear of Cancer Recurrence Inventory (FCRI)' and 'Coping Orientation to Problems Experienced Inventory-Revised (COPE-R)'.
Results: FCRI total score average within the scope of the study was calculated as 42.00 ± 18.88. Women's COPE-R total score average is 80.62 ± 13.20. There was a positive correlation between FCRI total score and COPE-R (r = 0.183, p = 0.009). According to the results of multiple linear regression analysis, age, education level, CAM usage, getting psychological support and COPE-R subscales (accommodation, avoidance, self-punishment) were associated with FCRI total score.
Conclusions: The fear of cancer recurrence experienced by breast cancer survivors was associated with their coping orientation. Determining the fear of cancer recurrence level and coping orientation of breast cancer survivors by healthcare professionals will guide the reduction of women's fear of cancer recurrence and further the development of adaptive coping orientation.
Nuseibeh B, Hoy M, Panoch J, Gowan T, Buckles D, Schwarz M Support Care Cancer. 2024; 32(12):776.
PMID: 39508951 DOI: 10.1007/s00520-024-08976-4.
The relationship between fear of cancer recurrence and posttraumatic growth: a meta-analysis.
Gu L, Shen C, Zhao L, Li N, Wang R, Dai L Front Psychol. 2024; 15:1373102.
PMID: 38887626 PMC: 11181912. DOI: 10.3389/fpsyg.2024.1373102.
Li B, Lin X, Chen S, Qian Z, Wu H, Liao G BMC Public Health. 2024; 24(1):440.
PMID: 38347483 PMC: 10860317. DOI: 10.1186/s12889-024-17969-1.
Lee H, Sin C, Kim H, Im H, Jo J, Lee Y Psychiatry Investig. 2023; 20(12):1204-1210.
PMID: 38011847 PMC: 10758328. DOI: 10.30773/pi.2023.0330.